Aryl-isoxazol-4-yl-imidazole derivatives
US7414061B2 · kind B2 · utility
1Cited by
0References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2006 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Feb 7, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I:wherein This class of compounds has high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.